Volume 19: Issue 2 (Oct 2020): Primary and Secondary Glomerular Diseases

Glassock RJ , Fervenza FC , Hebert L , Cameron JS : Nephrotic syndrome redux. Nephrol Dial Transplant 30: 12–17, 2015 PubMed

• Crossref
• PubMed
Glassock RJ , Fervenza FC , Hebert L , Cameron JS : Nephrotic syndrome redux. Nephrol Dial Transplant 30: 12–17, 2015 10.1093/ndt/gfu077 PubMed )| false
• Search Google Scholar
• Export Citation

van de Logt AE , Rijpma SR , Vink CH , Prudon-Rosmulder E , Wetzels JF , van Berkel M : The bias between different albumin assays may affect clinical decision-making. Kidney Int 95: 1514–1517, 2019 PubMed

• Crossref
• PubMed
van de Logt AE , Rijpma SR , Vink CH , Prudon-Rosmulder E , Wetzels JF , van Berkel M : The bias between different albumin assays may affect clinical decision-making. Kidney Int 95: 1514–1517, 2019 10.1016/j.kint.2019.01.042 PubMed )| false
• Search Google Scholar
• Export Citation

Meyrier A , Niaudet P : Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int 94: 861–869, 2018 PubMed

• Crossref
• PubMed
Meyrier A , Niaudet P : Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int 94: 861–869, 2018 10.1016/j.kint.2018.04.024 PubMed )| false
• Search Google Scholar
• Export Citation

Glassock RJ : Secondary minimal change disease. Nephrol Dial Transplant 18[Suppl 6]: vi52–vi58, 2003 PubMed

• Crossref
• PubMed
Glassock RJ : Secondary minimal change disease. Nephrol Dial Transplant 18[Suppl 6]: vi52–vi58, 2003 10.1093/ndt/gfg1060 PubMed )| false
• Search Google Scholar
• Export Citation

Shalhoub RJ : Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2: 556–560, 1974 PubMed

• Crossref
• PubMed
Shalhoub RJ : Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2: 556–560, 1974 10.1016/s0140-6736(74)91880-7 PubMed )| false
• Search Google Scholar
• Export Citation

Lagrue G , Xheneumont S , Branellec A , Hirbec G , Weil B : A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome. Biomedicine (Paris) 23: 37–40, 1975 PubMed

• PubMed
Lagrue G , Xheneumont S , Branellec A , Hirbec G , Weil B : A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome. Biomedicine (Paris) 23: 37–40, 1975 PubMed )| false
• Search Google Scholar
• Export Citation

Heslan JM , Branellec AI , Pilatte Y , Lang P , Lagrue G : Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome. Clin Exp Immunol 86: 157–162, 1991 PubMed

• Crossref
• PubMed
Heslan JM , Branellec AI , Pilatte Y , Lang P , Lagrue G : Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome. Clin Exp Immunol 86: 157–162, 1991 10.1111/j.1365-2249.1991.tb05789.x PubMed )| false
• Search Google Scholar
• Export Citation

Cheung PK , Stulp B , Immenschuh S , Borghuis T , Baller JF , Bakker WW : Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF. J Am Soc Nephrol 10: 1700–1708, 1999 PubMed

• PubMed
Cheung PK , Stulp B , Immenschuh S , Borghuis T , Baller JF , Bakker WW : Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF. J Am Soc Nephrol 10: 1700–1708, 1999 PubMed )| false
• Search Google Scholar
• Export Citation

Cheung PK , Klok PA , Baller JF , Bakker WW : Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int 57: 1512–1520, 2000 PubMed

• Crossref
• PubMed
Cheung PK , Klok PA , Baller JF , Bakker WW : Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int 57: 1512–1520, 2000 10.1046/j.1523-1755.2000.00996.x PubMed )| false
• Search Google Scholar
• Export Citation

Clement LC , Avila-Casado C , Macé C , Soria E , Bakker WW , Kersten S , et al.: Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 17: 117–122, 2011 PubMed

• Crossref
• PubMed
Clement LC , Avila-Casado C , Macé C , Soria E , Bakker WW , Kersten S , : Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 17: 117–122, 2011 10.1038/nm.2261 PubMed )| false
• Search Google Scholar
• Export Citation

Kondo S , Yoshizawa N , Kusumi Y , Takeuchi A , Torikata C : Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF). Clin Nephrol 52: 278–284, 1999 PubMed

• PubMed
Kondo S , Yoshizawa N , Kusumi Y , Takeuchi A , Torikata C : Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF). Clin Nephrol 52: 278–284, 1999 PubMed )| false
• Search Google Scholar
• Export Citation

Clement LC , Macé C , Avila-Casado C , Joles JA , Kersten S , Chugh SS : Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome. Nat Med 20: 37–46, 2014 PubMed

• Crossref
• PubMed
Clement LC , Macé C , Avila-Casado C , Joles JA , Kersten S , Chugh SS : Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome. Nat Med 20: 37–46, 2014 10.1038/nm.3396 PubMed )| false
• Search Google Scholar
• Export Citation

Lai KW , Wei CL , Tan LK , Tan PH , Chiang GS , Lee CG , et al.: Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 18: 1476–1485, 2007 PubMed

• Crossref
• PubMed
Lai KW , Wei CL , Tan LK , Tan PH , Chiang GS , Lee CG , : Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 18: 1476–1485, 2007 10.1681/ASN.2006070710 PubMed )| false
• Search Google Scholar
• Export Citation

Chugh SS , Clement LC , Macé C : New insights into human minimal change disease: Lessons from animal models. Am J Kidney Dis 59: 284–292, 2012 PubMed

• Crossref
• PubMed
Chugh SS , Clement LC , Macé C : New insights into human minimal change disease: Lessons from animal models. Am J Kidney Dis 59: 284–292, 2012 10.1053/j.ajkd.2011.07.024 PubMed )| false
• Search Google Scholar
• Export Citation

Garin EH , Blanchard DK , Matsushima K , Djeu JY : IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney Int 45: 1311–1317, 1994 PubMed

• Crossref
• PubMed
Garin EH , Blanchard DK , Matsushima K , Djeu JY : IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney Int 45: 1311–1317, 1994 10.1038/ki.1994.171 PubMed )| false
• Search Google Scholar
• Export Citation

Kim AH , Chung JJ , Akilesh S , Koziell A , Jain S , Hodgin JB , et al.: B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement. JCI Insight 2: e81836, 2017 PubMed

• Crossref
• PubMed
Kim AH , Chung JJ , Akilesh S , Koziell A , Jain S , Hodgin JB , : B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement. JCI Insight 2: e81836, 2017 10.1172/jci.insight.81836 PubMed )| false
• Search Google Scholar
• Export Citation

Boumediene A , Vachin P , Sendeyo K , Oniszczuk J , Zhang SY , Henique C , et al.: NEPHRUTIX: A randomized, double-blind, placebo vs rituximab-controlled trial assessing T-cell subset changes in minimal change nephrotic syndrome. J Autoimmun 88: 91–102, 2018 PubMed

• Crossref
• PubMed
Boumediene A , Vachin P , Sendeyo K , Oniszczuk J , Zhang SY , Henique C , : NEPHRUTIX: A randomized, double-blind, placebo vs rituximab-controlled trial assessing T-cell subset changes in minimal change nephrotic syndrome. J Autoimmun 88: 91–102, 2018 10.1016/j.jaut.2017.10.006 PubMed )| false
• Search Google Scholar
• Export Citation

Yoshikawa N , Nakanishi K , Sako M , Oba MS , Mori R , Ota E , et al.; Japanese Study Group of Kidney Disease in Children: A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment. Kidney Int 87: 225–232, 2015 PubMed

• Crossref
• PubMed
Yoshikawa N , Nakanishi K , Sako M , Oba MS , Mori R , Ota E , ; Japanese Study Group of Kidney Disease in Children: A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment. Kidney Int 87: 225–232, 2015 10.1038/ki.2014.260 PubMed )| false
• Search Google Scholar
• Export Citation

Sinha A , Saha A , Kumar M , Sharma S , Afzal K , Mehta A , et al.: Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome. Kidney Int 87: 217–224, 2015 PubMed

• Crossref
• PubMed
Sinha A , Saha A , Kumar M , Sharma S , Afzal K , Mehta A , : Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome. Kidney Int 87: 217–224, 2015 10.1038/ki.2014.240 PubMed )| false
• Search Google Scholar
• Export Citation

Webb NJA , Woolley RL , Lambe T , Frew E , Brettell EA , Barsoum EN , et al.; PREDNOS Collaborative Group: Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: Phase III randomised controlled trial and economic evaluation. BMJ 365: l1800, 2019 PubMed

• Crossref
• PubMed
Webb NJA , Woolley RL , Lambe T , Frew E , Brettell EA , Barsoum EN , ; PREDNOS Collaborative Group: Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: Phase III randomised controlled trial and economic evaluation. BMJ 365: l1800, 2019 10.1136/bmj.l1800 PubMed )| false
• Search Google Scholar
• Export Citation

Hahn D , Hodson EM , Willis NS , Craig JC : Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev CD001533: CD001533, 2015 PubMed

• Crossref
• PubMed
Hahn D , Hodson EM , Willis NS , Craig JC : Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev CD001533: CD001533, 2015 10.1002/14651858.CD001533.pub5 PubMed )| false
• Search Google Scholar
• Export Citation

Waldman M , Crew RJ , Valeri A , Busch J , Stokes B , Markowitz G , et al.: Adult minimal-change disease: Clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2: 445–453, 2007 PubMed

• Crossref
• PubMed
Waldman M , Crew RJ , Valeri A , Busch J , Stokes B , Markowitz G , : Adult minimal-change disease: Clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2: 445–453, 2007 10.2215/CJN.03531006 PubMed )| false
• Search Google Scholar
• Export Citation

Li H , Shi X , Shen H , Li X , Wang H , Li H , et al.: Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: A multicenter, open-label, nonrandomized cohort trial. Clin Ther 34: 1112–1120, 2012 PubMed

• Crossref
• PubMed
Li H , Shi X , Shen H , Li X , Wang H , Li H , : Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: A multicenter, open-label, nonrandomized cohort trial. Clin Ther 34: 1112–1120, 2012 10.1016/j.clinthera.2012.03.008 PubMed )| false
• Search Google Scholar
• Export Citation

Ponticelli C , Edefonti A , Ghio L , Rizzoni G , Rinaldi S , Gusmano R , et al.: Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial. Nephrol Dial Transplant 8: 1326–1332, 1993 PubMed

• PubMed
Ponticelli C , Edefonti A , Ghio L , Rizzoni G , Rinaldi S , Gusmano R , : Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial. Nephrol Dial Transplant 8: 1326–1332, 1993 PubMed )| false
• Search Google Scholar
• Export Citation

Li X , Li H , Chen J , He Q , Lv R , Lin W , et al.: Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome. Nephrol Dial Transplant 23: 1919–1925, 2008 PubMed

• Crossref
• PubMed
Li X , Li H , Chen J , He Q , Lv R , Lin W , : Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome. Nephrol Dial Transplant 23: 1919–1925, 2008 10.1093/ndt/gfm637 PubMed )| false
• Search Google Scholar
• Export Citation

Meyrier A , Condamin MC , Broneer D ; Collaborative Group of the French Society of Nephrology: Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: Minimal-change disease and focal-segmental glomerulosclerosis. Clin Nephrol 35[Suppl 1]: S37–S42, 1991 PubMed

• PubMed
Meyrier A , Condamin MC , Broneer D ; Collaborative Group of the French Society of Nephrology: Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: Minimal-change disease and focal-segmental glomerulosclerosis. Clin Nephrol 35[Suppl 1]: S37–S42, 1991 PubMed )| false
• Search Google Scholar
• Export Citation

Li X , Liu Z , Wang L , Wang R , Ding G , Shi W , et al.: Tacrolimus monotherapy after intravenous methylprednisolone in adults with minimal change nephrotic syndrome. J Am Soc Nephrol 28: 1286–1295, 2017 PubMed

• Crossref
• PubMed
Li X , Liu Z , Wang L , Wang R , Ding G , Shi W , : Tacrolimus monotherapy after intravenous methylprednisolone in adults with minimal change nephrotic syndrome. J Am Soc Nephrol 28: 1286–1295, 2017 10.1681/ASN.2016030342 PubMed )| false
• Search Google Scholar
• Export Citation

Medjeral-Thomas NR , Lawrence C , Condon M , Sood B , Warwicker P , Brown H , et al.: Randomized, controlled trial of tacrolimus and prednisolone monotherapy for adults with de novo minimal change disease: A multicenter, randomized, controlled trial. Clin J Am Soc Nephrol 15: 209–218, 2020 PubMed

• Crossref
• PubMed
Medjeral-Thomas NR , Lawrence C , Condon M , Sood B , Warwicker P , Brown H , : Randomized, controlled trial of tacrolimus and prednisolone monotherapy for adults with de novo minimal change disease: A multicenter, randomized, controlled trial. Clin J Am Soc Nephrol 15: 209–218, 2020 10.2215/CJN.06180519 PubMed )| false
• Search Google Scholar
• Export Citation

Gellermann J , Weber L , Pape L , Tönshoff B , Hoyer P , Querfeld U ; Gesellschaft für Pädiatrische Nephrologie (GPN): Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol 24: 1689–1697, 2013 PubMed

• Crossref
• PubMed
Gellermann J , Weber L , Pape L , Tönshoff B , Hoyer P , Querfeld U ; Gesellschaft für Pädiatrische Nephrologie (GPN): Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol 24: 1689–1697, 2013 10.1681/ASN.2012121200 PubMed )| false
• Search Google Scholar
• Export Citation

Geng HY , Ji LN , Chen CY , Tu J , Li HR , Bao R , et al.: [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome]. Zhonghua Er Ke Za Zhi 56: 651–656, 2018 PubMed

• Crossref
• PubMed
Geng HY , Ji LN , Chen CY , Tu J , Li HR , Bao R , : [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome]. Zhonghua Er Ke Za Zhi 56: 651–656, 2018 10.3760/cma.j.issn.0578-1310.2018.09.004 PubMed )| false
• Search Google Scholar
• Export Citation

Sinha A , Puraswani M , Kalaivani M , Goyal P , Hari P , Bagga A : Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: An open-label randomized controlled trial. Kidney Int 95: 210–218, 2019 PubMed

• Crossref
• PubMed
Sinha A , Puraswani M , Kalaivani M , Goyal P , Hari P , Bagga A : Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: An open-label randomized controlled trial. Kidney Int 95: 210–218, 2019 10.1016/j.kint.2018.08.039 PubMed )| false
• Search Google Scholar
• Export Citation

Rémy P , Audard V , Natella PA , Pelle G , Dussol B , Leray-Moragues H , et al.; MSN Trial Investigators: An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study). Kidney Int 94: 1217–1226, 2018 PubMed

• Crossref
• PubMed
Rémy P , Audard V , Natella PA , Pelle G , Dussol B , Leray-Moragues H , ; MSN Trial Investigators: An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study). Kidney Int 94: 1217–1226, 2018 10.1016/j.kint.2018.07.021 PubMed )| false
• Search Google Scholar
• Export Citation

Benz K , Dötsch J , Rascher W , Stachel D : Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 19: 794–797, 2004 PubMed

• Crossref
• PubMed
Benz K , Dötsch J , Rascher W , Stachel D : Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 19: 794–797, 2004 10.1007/s00467-004-1434-z PubMed )| false
• Search Google Scholar
• Export Citation

Iijima K , Sako M , Nozu K , Mori R , Tuchida N , Kamei K , et al.; Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group: Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384: 1273–1281, 2014 PubMed

• Crossref
• PubMed
Iijima K , Sako M , Nozu K , Mori R , Tuchida N , Kamei K , ; Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group: Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384: 1273–1281, 2014 10.1016/S0140-6736(14)60541-9 PubMed )| false
• Search Google Scholar
• Export Citation

Ravani P , Rossi R , Bonanni A , Quinn RR , Sica F , Bodria M , et al.: Rituximab in children with steroid-dependent nephrotic syndrome: A multicenter, open-label, noninferiority, randomized controlled trial. J Am Soc Nephrol 26: 2259–2266, 2015 PubMed

• Crossref
• PubMed
Ravani P , Rossi R , Bonanni A , Quinn RR , Sica F , Bodria M , : Rituximab in children with steroid-dependent nephrotic syndrome: A multicenter, open-label, noninferiority, randomized controlled trial. J Am Soc Nephrol 26: 2259–2266, 2015 10.1681/ASN.2014080799 PubMed )| false
• Search Google Scholar
• Export Citation

Ruggenenti P , Ruggiero B , Cravedi P , Vivarelli M , Massella L , Marasà M , et al.; Rituximab in Nephrotic Syndrome of Steroid-Dependent or Frequently Relapsing Minimal Change Disease Or Focal Segmental Glomerulosclerosis (NEMO) Study Group: Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. J Am Soc Nephrol 25: 850–863, 2014 PubMed

• Crossref
• PubMed
Ruggenenti P , Ruggiero B , Cravedi P , Vivarelli M , Massella L , Marasà M , ; Rituximab in Nephrotic Syndrome of Steroid-Dependent or Frequently Relapsing Minimal Change Disease Or Focal Segmental Glomerulosclerosis (NEMO) Study Group: Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. J Am Soc Nephrol 25: 850–863, 2014 10.1681/ASN.2013030251 PubMed )| false
• Search Google Scholar
• Export Citation

Webb H , Jaureguiberry G , Dufek S , Tullus K , Bockenhauer D : Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome. Pediatr Nephrol 31: 589–594, 2016 PubMed

• Crossref
• PubMed
Webb H , Jaureguiberry G , Dufek S , Tullus K , Bockenhauer D : Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome. Pediatr Nephrol 31: 589–594, 2016 10.1007/s00467-015-3245-9 PubMed )| false
• Search Google Scholar
• Export Citation

Basu B , Sander A , Roy B , Preussler S , Barua S , Mahapatra TKS , et al.: Efficacy of rituximab vs tacrolimus in pediatric corticosteroid-dependent nephrotic syndrome: A randomized clinical trial. JAMA Pediatr 172: 757–764, 2018 PubMed

• Crossref
• PubMed
Basu B , Sander A , Roy B , Preussler S , Barua S , Mahapatra TKS , : Efficacy of rituximab vs tacrolimus in pediatric corticosteroid-dependent nephrotic syndrome: A randomized clinical trial. JAMA Pediatr 172: 757–764, 2018 10.1001/jamapediatrics.2018.1323 PubMed )| false
• Search Google Scholar
• Export Citation

Hogan J , Dossier C , Kwon T , Macher MA , Maisin A , Couderc A , et al.: Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 34: 253–259, 2019 PubMed

• Crossref
• PubMed
Hogan J , Dossier C , Kwon T , Macher MA , Maisin A , Couderc A , : Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 34: 253–259, 2019 10.1007/s00467-018-4052-x PubMed )| false
• Search Google Scholar
• Export Citation

Chan EY , Webb H , Yu E , Ghiggeri GM , Kemper MJ , Ma AL , et al.: Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes. Kidney Int 97: 393–401, 2020 PubMed

• Crossref
• PubMed
Chan EY , Webb H , Yu E , Ghiggeri GM , Kemper MJ , Ma AL , : Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes. Kidney Int 97: 393–401, 2020 10.1016/j.kint.2019.09.033 PubMed )| false
• Search Google Scholar
• Export Citation

Ravani P , Magnasco A , Edefonti A , Murer L , Rossi R , Ghio L , et al.: Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: A randomized controlled trial. Clin J Am Soc Nephrol 6: 1308–1315, 2011 PubMed

• Crossref
• PubMed
Ravani P , Magnasco A , Edefonti A , Murer L , Rossi R , Ghio L , : Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: A randomized controlled trial. Clin J Am Soc Nephrol 6: 1308–1315, 2011 10.2215/CJN.09421010 PubMed )| false
• Search Google Scholar
• Export Citation

Ravani P , Ponticelli A , Siciliano C , Fornoni A , Magnasco A , Sica F , et al.: Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Kidney Int 84: 1025–1033, 2013 PubMed

• Crossref
• PubMed
Ravani P , Ponticelli A , Siciliano C , Fornoni A , Magnasco A , Sica F , : Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Kidney Int 84: 1025–1033, 2013 10.1038/ki.2013.211 PubMed )| false
• Search Google Scholar
• Export Citation

Magnasco A , Ravani P , Edefonti A , Murer L , Ghio L , Belingheri M , et al.: Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol 23: 1117–1124, 2012 PubMed

• Crossref
• PubMed
Magnasco A , Ravani P , Edefonti A , Murer L , Ghio L , Belingheri M , : Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol 23: 1117–1124, 2012 10.1681/ASN.2011080775 PubMed )| false
• Search Google Scholar
• Export Citation

Ravani P , Bonanni A , Ghiggeri GM : Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: Study protocol. BMJ Open 7: e013319, 2017 PubMed

• Crossref
• PubMed
Ravani P , Bonanni A , Ghiggeri GM : Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: Study protocol. BMJ Open 7: e013319, 2017 10.1136/bmjopen-2016-013319 PubMed )| false
• Search Google Scholar
• Export Citation

Iwabuchi Y , Miyabe Y , Makabe S , Nakano M , Manabe S , Karasawa K , et al.: Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to rituximab therapy between childhood-onset and adult-onset disease. Medicine (Baltimore) 97: e12704, 2018 PubMed

• Crossref
• PubMed
Iwabuchi Y , Miyabe Y , Makabe S , Nakano M , Manabe S , Karasawa K , : Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to rituximab therapy between childhood-onset and adult-onset disease. Medicine (Baltimore) 97: e12704, 2018 10.1097/MD.0000000000012704 PubMed )| false
• Search Google Scholar
• Export Citation

Fenoglio R , Sciascia S , Beltrame G , Mesiano P , Ferro M , Quattrocchio G , et al.: Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome. Oncotarget 9: 28799–28804, 2018 PubMed

• Crossref
• PubMed
Fenoglio R , Sciascia S , Beltrame G , Mesiano P , Ferro M , Quattrocchio G , : Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome. Oncotarget 9: 28799–28804, 2018 10.18632/oncotarget.25612 PubMed )| false
• Search Google Scholar
• Export Citation

Kronbichler A , Kerschbaum J , Fernandez-Fresnedo G , Hoxha E , Kurschat CE , Busch M , et al.: Rituximab treatment for relapsing minimal change disease and focal segmental glomerulosclerosis: A systematic review. Am J Nephrol 39: 322–330, 2014 PubMed

• Crossref
• PubMed
Kronbichler A , Kerschbaum J , Fernandez-Fresnedo G , Hoxha E , Kurschat CE , Busch M , : Rituximab treatment for relapsing minimal change disease and focal segmental glomerulosclerosis: A systematic review. Am J Nephrol 39: 322–330, 2014 10.1159/000360908 PubMed )| false
• Search Google Scholar
• Export Citation

Kittanamongkolchai W , Cheungpasitporn W , Zand L : Efficacy and safety of adrenocorticotropic hormone treatment in glomerular diseases: A systematic review and meta-analysis. Clin Kidney J 9: 387–396, 2016 PubMed

• Crossref
• PubMed
Kittanamongkolchai W , Cheungpasitporn W , Zand L : Efficacy and safety of adrenocorticotropic hormone treatment in glomerular diseases: A systematic review and meta-analysis. Clin Kidney J 9: 387–396, 2016 10.1093/ckj/sfw045 PubMed )| false
• Search Google Scholar
• Export Citation

Madan A , Mijovic-Das S , Stankovic A , Teehan G , Milward AS , Khastgir A : Acthar gel in the treatment of nephrotic syndrome: A multicenter retrospective case series. BMC Nephrol 17: 37, 2016 PubMed

• Crossref
• PubMed
Madan A , Mijovic-Das S , Stankovic A , Teehan G , Milward AS , Khastgir A : Acthar gel in the treatment of nephrotic syndrome: A multicenter retrospective case series. BMC Nephrol 17: 37, 2016 10.1186/s12882-016-0241-7 PubMed )| false
• Search Google Scholar
• Export Citation

Wang CS , Travers C , McCracken C , Leong T , Gbadegesin R , Quiroga A , et al.: Adrenocorticotropic hormone for childhood nephrotic syndrome: The ATLANTIS randomized trial. Clin J Am Soc Nephrol 13: 1859–1865, 2018 PubMed

• Crossref
• PubMed
Wang CS , Travers C , McCracken C , Leong T , Gbadegesin R , Quiroga A , : Adrenocorticotropic hormone for childhood nephrotic syndrome: The ATLANTIS randomized trial. Clin J Am Soc Nephrol 13: 1859–1865, 2018 10.2215/CJN.06890618 PubMed )| false
• Search Google Scholar
• Export Citation

Szeto CC , Lai FM , Chow KM , Kwan BC , Kwong VW , Leung CB , et al.: Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults. Am J Kidney Dis 65: 710–718, 2015 PubMed

• Crossref
• PubMed
Szeto CC , Lai FM , Chow KM , Kwan BC , Kwong VW , Leung CB , : Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults. Am J Kidney Dis 65: 710–718, 2015 10.1053/j.ajkd.2014.09.022 PubMed )| false
• Search Google Scholar
• Export Citation

Sethi S , Glassock RJ , Fervenza FC : Focal segmental glomerulosclerosis: Towards a better understanding for the practicing nephrologist. Nephrol Dial Transplant 30: 375–384, 2015 PubMed

• Crossref
• PubMed
Sethi S , Glassock RJ , Fervenza FC : Focal segmental glomerulosclerosis: Towards a better understanding for the practicing nephrologist. Nephrol Dial Transplant 30: 375–384, 2015 10.1093/ndt/gfu035 PubMed )| false
• Search Google Scholar
• Export Citation

Izzedine H , Launay-Vacher V , Bourry E , Brocheriou I , Karie S , Deray G : Drug-induced glomerulopathies. Expert Opin Drug Saf 5: 95–106, 2006 PubMed

• Crossref
• PubMed
Izzedine H , Launay-Vacher V , Bourry E , Brocheriou I , Karie S , Deray G : Drug-induced glomerulopathies. Expert Opin Drug Saf 5: 95–106, 2006 10.1517/14740338.5.1.95 PubMed )| false
• Search Google Scholar
• Export Citation

Chandra P , Kopp JB : Viruses and collapsing glomerulopathy: A brief critical review. Clin Kidney J 6: 1–5, 2013 PubMed

• Crossref
• PubMed
Chandra P , Kopp JB : Viruses and collapsing glomerulopathy: A brief critical review. Clin Kidney J 6: 1–5, 2013 10.1093/ckj/sft002 PubMed )| false
• Search Google Scholar
• Export Citation

Kambham N , Markowitz GS , Valeri AM , Lin J , D’Agati VD : Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59: 1498–1509, 2001 PubMed

• Crossref
• PubMed
Kambham N , Markowitz GS , Valeri AM , Lin J , D’Agati VD : Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59: 1498–1509, 2001 10.1046/j.1523-1755.2001.0590041498.x PubMed )| false
• Search Google Scholar
• Export Citation

Kriz W , Lemley KV : A potential role for mechanical forces in the detachment of podocytes and the progression of CKD. J Am Soc Nephrol 26: 258–269, 2015 PubMed

• Crossref
• PubMed
Kriz W , Lemley KV : A potential role for mechanical forces in the detachment of podocytes and the progression of CKD. J Am Soc Nephrol 26: 258–269, 2015 10.1681/ASN.2014030278 PubMed )| false
• Search Google Scholar
• Export Citation

Kriz W , Lemley KV : Potential relevance of shear stress for slit diaphragm and podocyte function. Kidney Int 91: 1283–1286, 2017 PubMed

• Crossref
• PubMed
Kriz W , Lemley KV : Potential relevance of shear stress for slit diaphragm and podocyte function. Kidney Int 91: 1283–1286, 2017 10.1016/j.kint.2017.02.032 PubMed )| false
• Search Google Scholar
• Export Citation

Campbell KN , Tumlin JA : Protecting podocytes: A key target for therapy of focal segmental glomerulosclerosis. Am J Nephrol 47[Suppl 1]: 14–29, 2018 PubMed

• Crossref
• PubMed
Campbell KN , Tumlin JA : Protecting podocytes: A key target for therapy of focal segmental glomerulosclerosis. Am J Nephrol 47[Suppl 1]: 14–29, 2018 10.1159/000481634 PubMed )| false
• Search Google Scholar
• Export Citation

Campbell KN , Wong JS , Gupta R , Asanuma K , Sudol M , He JC , et al.: Yes-associated protein (YAP) promotes cell survival by inhibiting proapoptotic dendrin signaling. J Biol Chem 288: 17057–17062, 2013 PubMed

• Crossref
• PubMed
Campbell KN , Wong JS , Gupta R , Asanuma K , Sudol M , He JC , : Yes-associated protein (YAP) promotes cell survival by inhibiting proapoptotic dendrin signaling. J Biol Chem 288: 17057–17062, 2013 10.1074/jbc.C113.457390 PubMed )| false
• Search Google Scholar
• Export Citation

Schwartzman M , Reginensi A , Wong JS , Basgen JM , Meliambro K , Nicholas SB , et al.: Podocyte-specific deletion of yes-associated protein causes FSGS and progressive renal failure. J Am Soc Nephrol 27: 216–226, 2016 PubMed

• Crossref
• PubMed
Schwartzman M , Reginensi A , Wong JS , Basgen JM , Meliambro K , Nicholas SB , : Podocyte-specific deletion of yes-associated protein causes FSGS and progressive renal failure. J Am Soc Nephrol 27: 216–226, 2016 10.1681/ASN.2014090916 PubMed )| false
• Search Google Scholar
• Export Citation

Wharram BL , Goyal M , Wiggins JE , Sanden SK , Hussain S , Filipiak WE , et al.: Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941–2952, 2005 PubMed

• Crossref
• PubMed
Wharram BL , Goyal M , Wiggins JE , Sanden SK , Hussain S , Filipiak WE , : Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941–2952, 2005 10.1681/ASN.2005010055 PubMed )| false
• Search Google Scholar
• Export Citation

Eng DG , Sunseri MW , Kaverina NV , Roeder SS , Pippin JW , Shankland SJ : Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis. Kidney Int 88: 999–1012, 2015 PubMed

• Crossref
• PubMed
Eng DG , Sunseri MW , Kaverina NV , Roeder SS , Pippin JW , Shankland SJ : Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis. Kidney Int 88: 999–1012, 2015 10.1038/ki.2015.152 PubMed )| false
• Search Google Scholar
• Export Citation

Kretzler M : Role of podocytes in focal sclerosis: defining the point of no return. J Am Soc Nephrol 16: 2830–2832, 2005 PubMed

• Crossref
• PubMed
Kretzler M : Role of podocytes in focal sclerosis: defining the point of no return. J Am Soc Nephrol 16: 2830–2832, 2005 10.1681/ASN.2005080841 PubMed )| false
• Search Google Scholar
• Export Citation

Savin VJ , Sharma M , Zhou J , Gennochi D , Fields T , Sharma R , et al.: Renal and hematological effects of CLCF-1, a B-cell-stimulating cytokine of the IL-6 family. J Immunol Res 2015: 714964, 2015 PubMed

• Crossref
• PubMed
Savin VJ , Sharma M , Zhou J , Gennochi D , Fields T , Sharma R , : Renal and hematological effects of CLCF-1, a B-cell-stimulating cytokine of the IL-6 family. J Immunol Res 2015: 714964, 2015 10.1155/2015/714964 PubMed )| false
• Search Google Scholar
• Export Citation

Wei C , El Hindi S , Li J , Fornoni A , Goes N , Sageshima J , et al.: Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17: 952–960, 2011 PubMed

• Crossref
• PubMed
Wei C , El Hindi S , Li J , Fornoni A , Goes N , Sageshima J , : Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17: 952–960, 2011 10.1038/nm.2411 PubMed )| false
• Search Google Scholar
• Export Citation

Delville M , Sigdel TK , Wei C , Li J , Hsieh SC , Fornoni A , et al.: A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Sci Transl Med 6: 256ra136, 2014 PubMed

• Crossref
• PubMed
Delville M , Sigdel TK , Wei C , Li J , Hsieh SC , Fornoni A , : A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Sci Transl Med 6: 256ra136, 2014 10.1126/scitranslmed.3008538 PubMed )| false
• Search Google Scholar
• Export Citation

Wada T , Nangaku M : A circulating permeability factor in focal segmental glomerulosclerosis: The hunt continues. Clin Kidney J 8: 708–715, 2015 PubMed

• Crossref
• PubMed
Wada T , Nangaku M : A circulating permeability factor in focal segmental glomerulosclerosis: The hunt continues. Clin Kidney J 8: 708–715, 2015 10.1093/ckj/sfv090 PubMed )| false
• Search Google Scholar
• Export Citation

Lepori N , Zand L , Sethi S , Fernandez-Juarez G , Fervenza FC : Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults. Clin Kidney J 11: 179–190, 2018 PubMed

• Crossref
• PubMed
Lepori N , Zand L , Sethi S , Fernandez-Juarez G , Fervenza FC : Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults. Clin Kidney J 11: 179–190, 2018 10.1093/ckj/sfx143 PubMed )| false
• Search Google Scholar
• Export Citation

De Vriese AS , Sethi S , Nath KA , Glassock RJ , Fervenza FC : Differentiating primary, genetic, and secondary FSGS in adults: A clinicopathologic approach. J Am Soc Nephrol 29: 759–774, 2018 PubMed

• Crossref
• PubMed
De Vriese AS , Sethi S , Nath KA , Glassock RJ , Fervenza FC : Differentiating primary, genetic, and secondary FSGS in adults: A clinicopathologic approach. J Am Soc Nephrol 29: 759–774, 2018 10.1681/ASN.2017090958 PubMed )| false
• Search Google Scholar
• Export Citation

Sethi S , Zand L , Nasr SH , Glassock RJ , Fervenza FC : Focal and segmental glomerulosclerosis: Clinical and kidney biopsy correlations. Clin Kidney J 7: 531–537, 2014 PubMed

• Crossref
• PubMed
Sethi S , Zand L , Nasr SH , Glassock RJ , Fervenza FC : Focal and segmental glomerulosclerosis: Clinical and kidney biopsy correlations. Clin Kidney J 7: 531–537, 2014 10.1093/ckj/sfu100 PubMed )| false
• Search Google Scholar
• Export Citation

Perkovic V , Jardine MJ , Neal B , Bompoint S , Heerspink HJL , Charytan DM , et al.; CREDENCE Trial Investigators: Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 380: 2295–2306, 2019 PubMed

• Crossref
• PubMed
Perkovic V , Jardine MJ , Neal B , Bompoint S , Heerspink HJL , Charytan DM , ; CREDENCE Trial Investigators: Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 380: 2295–2306, 2019 10.1056/NEJMoa1811744 PubMed )| false
• Search Google Scholar
• Export Citation

van den Berg JG , van den Bergh Weerman MA , Assmann KJ , Weening JJ , Florquin S : Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int 66: 1901–1906, 2004 PubMed

• Crossref
• PubMed
van den Berg JG , van den Bergh Weerman MA , Assmann KJ , Weening JJ , Florquin S : Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int 66: 1901–1906, 2004 10.1111/j.1523-1755.2004.00964.x PubMed )| false
• Search Google Scholar
• Export Citation

Deegens JK , Dijkman HB , Borm GF , Steenbergen EJ , van den Berg JG , Weening JJ , et al.: Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int 74: 1568–1576, 2008 PubMed

• Crossref
• PubMed
Deegens JK , Dijkman HB , Borm GF , Steenbergen EJ , van den Berg JG , Weening JJ , : Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int 74: 1568–1576, 2008 10.1038/ki.2008.413 PubMed )| false
• Search Google Scholar
• Export Citation

Maas RJ , Deegens JK , Smeets B , Moeller MJ , Wetzels JF : Minimal change disease and idiopathic FSGS: Manifestations of the same disease. Nat Rev Nephrol 12: 768–776, 2016 PubMed